These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation. Bennett JM; Hamblin TJ; Mufti GJ Leuk Res; 2011 Mar; 35(3):283-5. PubMed ID: 20971510 [No Abstract] [Full Text] [Related]
16. Update on myelodysplastic syndrome. Ho CM; Butera JN Med Health R I; 2009 Sep; 92(9):315-7. PubMed ID: 19842531 [No Abstract] [Full Text] [Related]
17. NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network. Oncology (Williston Park); 1998 Nov; 12(11A):53-80. PubMed ID: 10028503 [No Abstract] [Full Text] [Related]
18. Recent advances in the management of myelodysplastic syndromes. Hamblin T Hematol Oncol; 1993; 11 Suppl 1():27-31. PubMed ID: 8486338 [No Abstract] [Full Text] [Related]
19. [Further improvement of diagnosis and treatment of patients with myelodysplastic syndromes in China]. Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):505-6. PubMed ID: 22967400 [No Abstract] [Full Text] [Related]
20. Myeloproliferative neoplasms: diagnosis, management and treatment. Tonkin J; Francis Y; Pattinson A; Peters T; Taylor M; Thompson R; Wallis L Nurs Stand; 2012 Aug 22-28; 26(51):44-51. PubMed ID: 22953404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]